Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm

Angiology

Volumn 51, Issue 5, 2000, Pages 385-392

  Nakamura, Motoyuki ^a   Tachieda, Rintarou ^a   Niinuma, Hiroyuki ^a   Ohira, Atsushi ^a   Endoh, Shigeatsu ^a   Hiramori, Katsuhiko ^a   Makita, Shinji ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; COLLAGENASE; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA WALL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RADIOIMMUNOASSAY;

EID: 0034082739     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005100505     Document Type: Article

References (21)

1. Irizarry E, Newman KM, Gandhi RH, et al: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 54:571-574, 1993.
2. Newman KM, Ogata Y, Malon AM, et al: Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14:1315-1320, 1994.
3. Patel MI, Melrose J, Ghosh P, et al: Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24:82-92, 1996.
4. Sakalihasan N, Delvenne P, Nusgens BV, et al: Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127-133, 1996.
5. Knox JB, Sukhova GK, Whittemore AD, et al: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95:205-212, 1997.
6. McMillan WD, Tamarina NA, Cipollone M, et al: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 96:2228-2232, 1997.
7. Curci JA, Liao S, Huffman MD, et al: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102:1900-1910, 1998.
8. Diez J, Laviades C: Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 35:202-205, 1997.
9. Risteli J, Niemi S, Kauppila S, et al: Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand 266(suppl):183-188, 1995.
10. Takino T, Nakamura M, Hiramori K: Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodelling after myocardial infarction. Cardiology 91:81-86, 1999.
11. Risteli L, Risteli J: Noninvasive methods of detection of organ fibrosis. In: Connective Tissue in Health and Disease, ed. by Rojkind M. Boca Raton FL: CRC Press, 1990, 1:61-98.
12. Mesh CL, Baxter BT, Pearce WH, et al: Collagen and elastin gene expression in aortic aneurysms. Surgery 112:256-262, 1992.
13. Rizzo RJ, McCarthy WJ, Dixit SN, et al: Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 10:365-373, 1989.
14. Sumner DS, Hokanson DE, Strandness DE Jr: Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms. Surg Gynecol Obstet 130:459-466, 1970.
15. Satta J, Haukipuro K, Kairaluoma MI, et al: Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg 25:909-915, 1997.
16. Satta J, Juvonen T, Haukipuro K, et al: Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 22:155-160, 1995.
17. McMillan WD, Pearce WH: Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122-127, 1999.
18. Newman KM, Malon AM, Shin RD, et al: Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Conn Tiss Res 30:265-276, 1994.
19. Tamarina NA, McMillan WD, Shively VP, et al: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122:264-272, 1997.
20. Webster MW, McAuley CE, Steed DL, et al: Collagen stability and collagenolytic activity in the normal and aneurysmal human abdominal aorta. Am J Surg 161:635-638, 1991.
21. Allaire E, Forough R, Clowes M, et al: Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420, 1998.